Buy & Sell Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) – Bio-Rad Laboratories, Inc. Class A Common Stock Price Today
Aura AI Summary
Key Stats
- $7.86BMarket Cap
- HealthSector
- -20.92%3M Drawdown
- $7.67BEnterprise Value
- -Dividend Yield
- 54 daysTypical Hold Time
Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) is currently valued at a market capitalization of $7.86B, with an enterprise value of $7.67B. Over the past 52 weeks, Bio-Rad Laboratories, Inc. Class A Common Stock has traded between a low of $225.56 and a high of $339.75, highlighting its annual price range. Over the past three months, Bio-Rad Laboratories, Inc. Class A Common Stock has recorded a drawdown of -20.92%, reflecting recent price volatility. On average, investors hold Bio-Rad Laboratories, Inc. Class A Common Stock for approximately 54 days, indicating typical investor behavior on the platform.
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Most Recent News
Xcel Brands shares jump after Coco Rocha collaboration announcement
Xcel Brands' stock surged over 100% intraday and closed up 10.53% after announcing a new exclusive licensing partnership between its handbag brand Baggallini and model-entrepreneur Coco Rocha. The collaboration will launch a limited-edition capsule c...
Anterix focuses on monetizing 900 MHz spectrum for private broadband with stable $69 price target.
Anterix Inc. is leveraging its 900 MHz radio spectrum to build private broadband networks for utility and critical infrastructure clients, aiming for long-term growth through new products and satellite connectivity. The company enjoys strong institut...
Jumia reports deeply negative ROIC amid aggressive growth, highlighting challenges in capital efficiency.
Jumia Technologies AG, a leading African e-commerce platform, currently shows a highly negative Return on Invested Capital (ROIC) of -256.50%, reflecting its aggressive growth and market expansion strategy. This negative ROIC, compared to its Weighte...
